Friday, March 13th, 2009
10:00 a.m. – 3:35 p.m. CST Takeda Global Research & Development Center, Inc.
Lake Forest, IL 60045
RESERVE EARLY; LIMITED SEATING!!!!!
Agenda:
9:30-10:00 AM
Registration
10:00-10:15 AM
Opening Remarks & Welcome Nancy Joseph-Ridge, M.D.
President, Takeda Global Research &
Development Center
Brief Overview: History and Goals of the Symposium
Ron Kirschner, M.D.
President, Heartland Angels
10:15- 10:45 AM
Keynote Address Stephen Brannan
Executive Medical Director
Neuroscience, Takeda Global Research & Development Center, Inc
. Depression R&D: Clinical Development of Therapeutic Agents
and Recent Breakthroughs
10:45-11:15 AM
Abstract Presentation
Angelos Halaris and John Piletz Loyola University, Maywood,
Illinois.
Depression as a Cardiovascular Disease Risk Factor: Novel Approaches to
Treatment
11:15-11:30 AM
Break
11:30-12:30 PM
Roundtables
Section I: TBA
Section II: TBA
12:30-1:30 PM
Lunch and Poster Discussions
1:30-2:00 PM
Keynote Address Leonardo Sahelijo, M.D.
Director, Pharmacogenomics, Takeda Global Research & Development Center, Inc.
2:00-2:30 PM
Abstract Presentation
Marquis P. Vawter, M.S.Ed., Ph.D.,
AbaStar MDx™ Inc.
Blood-Based RNA Gene Expression Tests for the Accurate
Diagnosis of Mental and Neurodegenerative Disorders
2:30-2:45 PM
Break
2:45-3:45 PM
Roundtables
Section III: TBA
Section IV: TBA
End of Formal Program, Start of New Informational Sessions
Session A:
4:00- 4:45 PM
Group I:
Early Stage Investing: Angel and Venture Capital Investors Ron Kirschner, MD, MBA
President Heartland Angels, Inc.
4:00- 4:45 PM
Group II:
Panel Discussion Andy Hull
VP of Global Alliance Management, Takeda Global Research &
Development Center, Inc.
Matthew Raymond, Ph.D.
Director of Intellectual Property, Rush University
Mary Gardner
Hospira, Director, Technology Assessment
Session B:
4:00- 5:15 PM
Networking: Connecting, Re-connecting and Feedback
